Vitamin C May Boost Survival in Early-Stage Blood Cancer Patients, Study Finds

A recent clinical trial reported by ScienceDaily Science indicates that daily vitamin C supplementation could improve survival rates for individuals with precancerous blood disorders and early-stage blood cancers. Participants who received the supplement experienced fewer adverse events compared to those who did not, and the data suggest a promising survival advantage. The findings raise optimism that a widely available vitamin might help protect against complications associated with leukemia and related conditions. While the study offers encouraging evidence, further research is needed to confirm the benefits and establish optimal dosing for patients.